Immune mechanisms in oral lichen planus
- PMID: 11501887
- DOI: 10.1080/000163501750266774
Immune mechanisms in oral lichen planus
Abstract
Although we still don't know the cause, there has been much research into the immune and pathological mechanisms that underlie oral lichen planus (OLP) and it is now possible to piece together a much clearer picture of the disease process. There is consensus that in OLP there is chronic, cell-mediated, immune damage to basal keratinocytes in the oral mucosa that are recognized as being antigenically foreign or altered. In most cases, however, the identity of the target antigen remains unknown. It is likely that cytokines released by the affected keratinocytes, and the associated inflammatory infiltrate, play a key role in the selective recruitment of the T-cell-dominated infiltrate that characterizes OLP, through their ability to induce adhesion molecule expression as well as further cytokine and chemokine release. In susceptible individuals, chronic presentation of antigen by basal keratinocytes may perpetuate the condition and direct cell-mediated immune damage on the keratinocytes.
Similar articles
-
Pathogenesis of oral lichen planus--a review.J Oral Pathol Med. 2010 Nov;39(10):729-34. doi: 10.1111/j.1600-0714.2010.00946.x. Epub 2010 Oct 4. J Oral Pathol Med. 2010. PMID: 20923445 Review.
-
Disease mechanisms in oral lichen planus. A possible role for autoimmunity.Australas J Dermatol. 1993;34(2):63-9. doi: 10.1111/j.1440-0960.1993.tb00860.x. Australas J Dermatol. 1993. PMID: 8311830
-
The high expression level of programmed death-1 ligand 2 in oral lichen planus and the possible costimulatory effect on human T cells.J Oral Pathol Med. 2011 Aug;40(7):525-32. doi: 10.1111/j.1600-0714.2011.01035.x. Epub 2011 Apr 2. J Oral Pathol Med. 2011. PMID: 21457347
-
The possible roles of OPN-regulated CEACAM1 expression in promoting the survival of activated T cells and the apoptosis of oral keratinocytes in oral lichen planus patients.J Clin Immunol. 2011 Oct;31(5):827-39. doi: 10.1007/s10875-011-9552-4. Epub 2011 Jun 14. J Clin Immunol. 2011. PMID: 21671129
-
Mast cell/T cell interactions in oral lichen planus.J Oral Pathol Med. 2002 Apr;31(4):189-95. doi: 10.1034/j.1600-0714.2002.310401.x. J Oral Pathol Med. 2002. PMID: 12076321 Review.
Cited by
-
A case of erosive oral lichen planus in a child affected by β-Thalassemia after 5 years from bone marrow transplantation.BMC Oral Health. 2025 Jul 26;25(1):1252. doi: 10.1186/s12903-025-06641-8. BMC Oral Health. 2025. PMID: 40713557 Free PMC article.
-
Photodynamic therapy in treatment of oral lichen planus.J Clin Med Res. 2015 Jun;7(6):393-9. doi: 10.14740/jocmr2147w. Epub 2015 Apr 8. J Clin Med Res. 2015. PMID: 25883701 Free PMC article. Review.
-
Comparative Efficacy and Safety of Interventions for the Treatment of Oral Lichen Planus: A Systematic Review and Network Meta-Analysis.J Clin Med. 2023 Apr 7;12(8):2763. doi: 10.3390/jcm12082763. J Clin Med. 2023. PMID: 37109100 Free PMC article. Review.
-
Langerhans Cells, T Cells, and B Cells in Oral Lichen Planus and Oral Leukoplakia.Int J Dent. 2022 Mar 22;2022:5430309. doi: 10.1155/2022/5430309. eCollection 2022. Int J Dent. 2022. PMID: 35360707 Free PMC article.
-
Tissue-specific regulation of CXCL9/10/11 chemokines in keratinocytes: Implications for oral inflammatory disease.PLoS One. 2017 Mar 2;12(3):e0172821. doi: 10.1371/journal.pone.0172821. eCollection 2017. PLoS One. 2017. PMID: 28253295 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources